乳房生検の世界市場2017-2021

Technavioが発行した調査報告書(IRTNTR11441)
◆英語タイトル:Global Breast Biopsy Market 2017-2021
◆商品コード:IRTNTR11441
◆発行会社(リサーチ会社):Technavio
◆発行日:2017年3月10日
◆ページ数:70
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。

当調査レポートでは、乳房生検の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、乳房生検の世界市場規模及び予測、製品別分析、需要先別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・乳房生検の世界市場:市場概観
・乳房生検の世界市場:業界の構造分析
・乳房生検の世界市場:市場規模及び予測
・乳房生検の世界市場:製品別分析
・乳房生検の世界市場:需要先別分析
・乳房生検の世界市場:地域別分析
・乳房生検の世界市場:アジア市場規模
・乳房生検の世界市場:アメリカ市場規模
・乳房生検の世界市場:ヨーロッパ市場規模
・乳房生検の世界市場:成長要因
・乳房生検の世界市場:課題
・乳房生検の世界市場:市場シェア
・乳房生検の世界市場:市場動向
・乳房生検の世界市場:競争状況
・乳房生検の世界市場:主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。
【レポートの概要】

About Breast BiopsyA breast biopsy is a procedure that involves the removal of tissue or fluid from the targeted area. The tissue is examined under a microscope and then tested to determine the presence of breast cancer. A biopsy is the only diagnostic procedure to confirm cancer. About 80% of women who undergo breast biopsy do not have breast cancer.

Technavio’s analysts forecast the global breast biopsy market to grow at a CAGR of 10.70% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global breast biopsy market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of breast biopsy devices.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Breast Biopsy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• BD
• C.R. Bard
• Hologic
• Leica Biosystems

[Other prominent vendors]
• Argon Medical Devices
• Aurora Imaging
• Biopsybell
• Bracco Imaging
• Carestream Health
• Cook Medical
• Fischer Medical Technologies
• Imaging Equipment
• Intact Medical (a subsidiary of Medtronic)
• Internazionale Medico Scientifica
• Metaltronica
• NuVue Therapeutics
• PerkinElmer
• Planmed OY
• Sectra
• STERYLAB
• Terason
• ZAMAR CARE

[Market driver]
• Growing incidence of breast cancer
• For a full, detailed list, view our report

[Market challenge]
• Complications and risks associated with breast biopsies
• For a full, detailed list, view our report

[Market trend]
• Increase in reimbursement for breast biopsy
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights
• Top-vendor offerings

PART 05: Breast cancer: An overview
• Background
• Breast cancer
• Breast biopsy

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Market segmentation by product type
• Market overview
• Global breast biopsy imaging guidance systems market
• Global breast biopsy needles market
• Global breast biopsy needle-based systems market
• Others

PART 08: Market segmentation by modality
• Global breast biopsy market by modality

PART 09: Market segmentation by end-user
• Hospitals
• ASCs
• Research centers
• Others

PART 10: Geographical segmentation
• Breast biopsy market in Americas
• Breast biopsy market in EMEA
• Breast biopsy market in APAC

PART 11: Decision framework

PART 12: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 13: Market trends
• Increase in reimbursement for breast biopsy
• Growing demand for MRI and ultrasound-guided breast biopsy procedures
• Emergence of breast liquid biopsy tests

PART 14: Vendor landscape
• Competitive landscape

PART 15: Key vendor analysis
• BD
• C.R. Bard
• Hologic
• Leica Biosystems
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Percentage of cancer types worldwide 2012
Exhibit 03: Breast cancer stages by tumor size and extent of metastasis
Exhibit 04: Snapshot of global breast biopsy market
Exhibit 05: Global breast biopsy market 2016-2021 ($ millions)
Exhibit 06: Five forces analysis
Exhibit 07: Global breast biopsy market by product type
Exhibit 08: Most common biopsies for breast cancer
Exhibit 09: Global breast biopsy market by product type 2016-2021
Exhibit 10: Global breast biopsy market by product analysis 2016
Exhibit 11: Global breast biopsy market growth lifecycle analysis 2016
Exhibit 12: Global breast biopsy market by product 2016-2021 ($ millions)
Exhibit 13: Global breast biopsy market by product 2016-2021 (%)
Exhibit 14: Global breast biopsy imaging guidance systems market 2016-2021 ($ millions)
Exhibit 15: Benefits of advanced biopsy needles
Exhibit 16: Global breast biopsy needles market 2016-2021 ($ millions)
Exhibit 17: Global needle-based breast biopsy systems market 2016-2021 ($ millions)
Exhibit 18: Global other breast biopsy devices market 2016-2021 ($ millions)
Exhibit 19: Global breast biopsy market by modality
Exhibit 20: Global breast biopsy market by modality 2016 (%)
Exhibit 21: Global breast biopsy market by end-user 2016
Exhibit 22: Global breast biopsy market by geography 2016-2021
Exhibit 23: Global breast biopsy market analysis by geography 2016
Exhibit 24: Geographical presence of global breast biopsy market
Exhibit 25: Geographical overview of global breast biopsy market 2016-2021
Exhibit 26: Breast biopsy market in Americas 2016-2021 ($ millions)
Exhibit 27: Estimated number of new cancer cases and deaths in US 2016 (1000s)
Exhibit 28: Top four EMEA countries population over 65 years of age 2015 (%)
Exhibit 29: Breast biopsy market in EMEA 2016-2021 ($ millions)
Exhibit 30: Breast biopsy market in APAC 2016-2021 ($ millions)
Exhibit 31: Global breast biopsy market by geography 2016-2021 ($ millions)
Exhibit 32: Global breast biopsy market by geography 2016-2021 (%)
Exhibit 33: Government initiatives for cancer and liquid biopsy testing in some countries
Exhibit 34: Impact of drivers
Exhibit 35: Cost of biopsies for uninsured people in US 2015
Exhibit 36: Impact of challenges
Exhibit 37: Breast biopsy facility payment in US
Exhibit 38: Competitive structure of global breast biopsy market
Exhibit 39: Competitive parameters in global breast biopsy market
Exhibit 40: Market penetration of breast biopsy market vendors 2016
Exhibit 41: Global breast biopsy market share analysis 2016
Exhibit 42: Key highlights of BD
Exhibit 43: BD: Strength assessment
Exhibit 44: BD: Strategy assessment
Exhibit 45: BD: Opportunity assessment
Exhibit 46: C.R. Bard: Strength assessment
Exhibit 47: C.R. Bard: Strategy assessment
Exhibit 48: C.R. Bard: Opportunity assessment
Exhibit 49: Key highlights of Hologic
Exhibit 50: Hologic: Strength assessment
Exhibit 51: Hologic: Strategy assessment
Exhibit 52: Hologic: Opportunity assessment
Exhibit 53: Key highlights of Leica Biosystems
Exhibit 54: Leica Biosystems: Strength assessment
Exhibit 55: Leica Biosystems: Strategy assessment
Exhibit 56: Leica Biosystems: Opportunity assessment



【掲載企業】

BD, C.R. Bard, Hologic, Leica Biosystems, Argon Medical Devices, Aurora Imaging, Biopsybell, Bracco Imaging, Carestream Health, Cook Medical, Fischer Medical Technologies, Imaging Equipment, Intact Medical, Internazionale Medico Scientifica, Metaltronica, NuVue Therapeutics, PerkinElmer, Planmed OY, Sectra, STERYLAB, Terason, and ZAMAR CARE.

【レポートのキーワード】

乳房生検、乳房生検装置

【リサーチ方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 乳房生検の世界市場2017-2021(Global Breast Biopsy Market 2017-2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆